|1.||Rotshild, Victoria: 1 article (07/2008)|
|2.||Makhoul, Rola: 1 article (07/2008)|
|3.||Averbuch, Diana: 1 article (07/2008)|
|4.||Engelhard, Dan: 1 article (07/2008)|
|5.||Weintraub, Michael: 1 article (07/2008)|
|6.||Macchia, D: 1 article (01/2007)|
|7.||Ermini, G: 1 article (01/2007)|
|8.||Severino, M: 1 article (01/2007)|
|9.||Cecchi, L: 1 article (01/2007)|
|10.||Campi, P: 1 article (01/2007)|
11/01/1984 - "Seventeen women received 1.0 g of cefonicid, and all cervical infections were cured. "
08/01/1998 - "Cefonicid, with its several immunoproperties observed in this study, possesses interesting beneficial properties which make it suitable for the treatment of infections in patients with impaired components of the immune system."
02/01/1991 - "The results of the present study indicate that a single dose of 1 g of cefonicid given intramuscularly is useful as prophylaxis and treatment of gynecological infections."
09/01/1998 - "Cefonicid also decreased the treatment cost of infection per patient ($49.80 versus $364.87). "
09/01/1998 - "Cefonicid significantly decreased severe infections requiring hospitalization (placebo 8% versus cefonicid 1%; P = 0.033). "
04/01/1982 - "Therefore, the efficacy of cefonicid in treatment of men with uncomplicated gonococcal urethritis was evaluated in a two-phase study. "
11/01/1984 - "The efficacy of 1.0 g of cefonicid was evaluated noncomparatively in 50 men with gonococcal urethritis; four failed to respond to treatment. "
02/01/1984 - "Young men with uncomplicated gonococcal urethritis were treated with 1 gram of cefonicid given intramuscularly plus 1 gram of probenecid by mouth. "
02/01/1984 - "Cefonicid as therapy for uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae."
04/01/1982 - "Of the 85 pretreatment and four posttreatment isolates tested, 31 were inhibited by less than 0.0625 microgram of penicillin/ml and 87 were inhibited by less than 1.0 microgram/ml. Twenty-eight of the 89 isolates were inhibited by less than 0.0625 microgram of cefonicid/ml and 88, by less than 1.0 microgram of cefonicid/ml. It is concluded that 1.0 g of cefonicid given intramuscularly is effective therapy for uncomplicated gonococcal urethritis."
|3.||Urinary Tract Infections (Urinary Tract Infection)
01/01/1991 - "Therapeutic efficacy and renal effects of cefonicid in the treatment of difficult urinary tract infections."
11/01/1984 - "Cefonicid is an effective single-dose agent in uncomplicated lower urinary tract infection."
11/01/1984 - "In a randomized double-blind comparison of cefonicid (dose, 1.0 g every 24 hr) and cefmandole (dose, 1.0 g iv every 6 hr), 147 hospitalized patients (105 men, 42 women) with urinary tract infections (UTIs) were assessed. "
06/01/1983 - "Single-dose cefonicid therapy for urinary tract infections."
06/01/1983 - "Of 50 patients with symptoms of lower urinary tract infection randomized to receive either cefonicid or amoxicillin, 39 were infected with greater than or equal to 10(5) bacteria per ml. At early posttherapy follow-up (5 to 18 days), 19 of 21 (90%) cefonicid-treated patients and 16 of 18 (89%) amoxicillin-treated patients were cured. "
|4.||Respiratory Tract Infections (Respiratory Tract Infection)
01/01/1990 - "Our results show that cefonicid was well distributed in interstitial fluid from which pulmonary lymph is formed and that its concentrations in lung tissue and lymph nodes were sufficient to inhibit most pathogens involved in respiratory tract infections. "
06/01/1987 - "[Efficacy and tolerance of cefonicid in the treatment of respiratory infections]."
06/01/1987 - "A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens."
11/01/1984 - "Overall rates of favorable response to cefonicid therapy, by disease, were 88.4%, urinary tract infections; 91.4%, lower respiratory tract infections; 95.1%, skin and skin-structure infections; and 91.3%, bone and joint infections. "
01/01/1985 - "Cefonicid was clinically effective in 92% of skin and soft tissue infections, 74% of bone and joint infections, 83% of respiratory tract infections, and 95% of urinary tract infections. "
04/01/1991 - "[Cefonicid efficacy in the treatment of community-acquired pneumonia]."
01/01/1988 - "Cefonicid's demonstrated safety and efficacy, its low cost, and its long half-life, permitting once-daily dosing, make this antibiotic an ideal parenteral choice for empiric therapy of community-acquired pneumonia."
01/01/1988 - "Cefonicid, a long-acting cephalosporin, is a useful and cost-effective antibiotic that is active against many of the common pathogens that cause community-acquired pneumonia, such as Streptococcus pneumoniae and Haemophilus influenzae. "
02/01/1982 - "Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia."
09/01/1989 - "The cost and relative use of cefonicid and cefuroxime were examined in specific patients with pneumonia--those assigned to diagnosis-related group 89--for whom either drug was prescribed. "
|5.||Cefoxitin (Cefoxitin Sodium)
|6.||Anti-Bacterial Agents (Antibiotics)
|8.||Cephalosporins (Cephalosporin Antibiotics)
|4.||Renal Dialysis (Hemodialysis)
|5.||Cesarean Section (Caesarean Section)